首页> 外国专利> BI-OR POLYSPECIFIC POLYEPEPTIDES BINDING SURFACE ANTIGENES OF IMMUNE EFFECTIVE CELLS AND HBV ANTIGENS FOR THE TREATMENT OF BV INFECTIONS AND ASSOCIATED STATES THEREOF

BI-OR POLYSPECIFIC POLYEPEPTIDES BINDING SURFACE ANTIGENES OF IMMUNE EFFECTIVE CELLS AND HBV ANTIGENS FOR THE TREATMENT OF BV INFECTIONS AND ASSOCIATED STATES THEREOF

机译:结合免疫原性细胞和HBV抗原表面抗原的双或多肽多肽,用于治疗BV感染及其相关状态

摘要

The present invention relates to a polypeptide comprising (a) a first set of six complementarity determining regions (CDRs) configured to bind a first antigen; and (b) (ba) a second set of six CDRs configured to bind a second antigen; or (bb) a ligand capable of binding to a second antigen; wherein (i) said first antigen is selected from Hepatitis B virus (HBV) small surface antigen; HBV medium surface antigen; and HBV large surface antigen; and (ii) said second antigen is selected from surface antigens presented by immune effector cells such as natural killer (NK) cells and cytotoxic T lymphocytes (CTLs). Also provided are compositions for use in a method of treating or preventing HBV infection and/or a condition caused by said HBV infection, said condition caused by said HBV infection being selected from liver cirrhosis and hepatocellular carcinoma.
机译:本发明涉及一种多肽,其包含:(a)配置为结合第一抗原的第一组六个互补决定区(CDR); (b)(ba)配置成结合第二抗原的第二组六个CDR; (bb)能够结合第二抗原的配体;或(i)所述第一抗原选自乙肝病毒(HBV)小表面抗原; HBV培养基表面抗原; HBV大表面抗原; (ii)所述第二抗原选自免疫效应细胞例如天然杀伤(NK)细胞和细胞毒性T淋巴细胞(CTL)提供的表面抗原。还提供了用于治疗或预防HBV感染和/或由所述HBV感染引起的病症的组合物,所述由所述HBV感染引起的病症选自肝硬化和肝细胞癌。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号